Results 81 to 90 of about 47,700 (222)
BMC Research Notes, 2018 Objective Based on studies in India (as there was no studies from outside India) amphotericin B deoxycholate has been considered as a backup drug for treatment of visceral leishmaniasis.
Md Golam Hasnain +7 more
doaj +1 more source
Phlebotominae Sand Flies in Paraguay. Abundance Distribution in the Southeastern Region [PDF]
, 2003 From September 1993 to August 2001, 7,190 phlebotomine were collected with CDC light trap in an endemic area for human leishmaniasis, in the departments of Misiones and Itapúa, Paraguay.
Cousiño, Blanca +6 more
core +3 more sources
Immunobiology of visceral leishmaniasis [PDF]
Frontiers in Immunology, 2012 Visceral leishmaniasis (VL), commonly known as kala-azar, is caused by Leishmania donovani and Leishmania infantum (Leishmania chagasi in the Americas). These Leishmania species infect macrophages throughout the viscera, and parasites are typically found in the spleen, liver, and bone marrow.
Kumar, Rajiv, Nylén, Susanne
openaire +3 more sources
Clinical and Translational Science, Volume 19, Issue 4, April 2026.ABSTRACT Cutaneous leishmaniasis is a neglected tropical disease with only one oral treatment option. DNDI‐6148 is an orally bioavailable compound with potent antiparasitic activity in preclinical studies. Establishing skin target‐site pharmacokinetic/pharmacodynamic (PK/PD) relationships is essential to enable its clinical development.
Rasmus Hansen Henninger +7 more
wiley +1 more source
The use of K39 test in the diagnosis of visceral leishmaniasis [PDF]
, 2007 From time to time patients admitted with fever of unknown origin prove to be a diagnostic dilemma. While textbooks describe typical symptoms and signs, and also diagnostic tests, these are not always helpful.
Sciberras, Robert
core
Management of trypanosomiasis and leishmaniasis [PDF]
, 2012 <p>Background: The current treatments for human African trypanosomiasis (HAT), Chagas disease and leishmaniasis (collectively referred to as the kinetoplastid diseases) are far from ideal but, for some, there has been significant recent progress ...
Alsford +39 more
core +2 more sources
Diagnosis of visceral leishmaniasis [PDF]
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2011 Leishmaniasis is a vector-borne disease with up to 350 million people at risk of infection worldwide. Among its different clinical manifestations, visceral is the most severe form. Since clinical features of visceral leishmaniasis (VL) mimic several other common diseases, accurate diagnosis is crucial as the treatment is associated with significant ...
Pankaj, Srivastava +3 more
openaire +2 more sources
Parasite Immunology, Volume 48, Issue 4, April 2026.ABSTRACT Zoonotic visceral leishmaniasis is caused by Leishmania (Leishmania) infantum. Dogs are considered the most critical urban reservoirs of L. (L.) infantum due to their high infection rate and direct transmission to humans. The parasite has developed mechanisms to evade the host's defence system by inhibiting macrophage activation, thereby ...
Gabriela Lovizutto Venturin +5 more
wiley +1 more source
Seroepidemiology of Visceral Leishmaniasis In Ardabil Province During 2002-2011 [PDF]
Background & Objectives: Visceral leishmaniasis is caused by a protozoan called Leishmania, that is a fatal disease for human. In Iran, this disease is caused by Leishmania infantum and occurres in early ages.
امدادی, داريوش +2 more
core